Related Experiment Video
Updated: May 8, 2026

05:46
Correction of Presbyopia by Monocular Bi-Aspheric Ablation Profile
Published on: September 20, 2024
Intraocular lens power calculation after myopic and hyperopic laser vision correction using optical coherence
Maolong Tang1, Li Wang, Douglas D Koch
1Center for Ophthalmic Optics and Lasers, Casey Eye Institute, Oregon Health & Science University, Portland, OR, USA.
Summary
Optical coherence tomography (OCT) precisely measures corneal power for intraocular lens (IOL) calculations. This OCT-based method shows accuracy comparable to existing formulas in eyes with prior laser vision correction (LVC).
Area of Science:
- Ophthalmology
- Biomedical Optics
- Refractive Surgery
Background:
- Accurate intraocular lens (IOL) power calculation is crucial for successful cataract surgery outcomes.
- Previous laser vision correction (LVC) significantly alters corneal power, complicating standard IOL calculations.
- Existing formulas may not adequately address refractive changes after LVC.
Purpose of the Study:
- To evaluate the precision of optical coherence tomography (OCT) for measuring corneal power in eyes with a history of myopic and hyperopic LVC.
- To develop and assess an OCT-based formula for intraocular lens (IOL) power calculation in post-LVC cataract patients.
- To compare the refractive prediction accuracy of the OCT-based IOL formula against the established Haigis-L formula.
Main Methods:
- Prospective study enrolling patients with prior LVC undergoing cataract surgery at two specialized eye centers.
- Corneal power measurement using a Fourier-domain OCT system, with intravisit repeatability assessed.
- Axial length, anterior chamber depth, and keratometry measured using the IOLMaster.
- Development of an OCT-based IOL formula and calculation of its mean absolute error (MAE).
Main Results:
- The intravisit repeatability of OCT corneal power measurement was found to be 0.24 D.
- In the myopic LVC group, the OCT formula achieved a MAE of 0.57 D, compared to 0.73 D for the Haigis-L formula.
- In the hyperopic LVC group, the OCT formula yielded a MAE of 0.26 D, outperforming the Haigis-L formula's MAE of 0.54 D.
Conclusions:
- Optical coherence tomography (OCT) provides precise measurements of corneal power.
- An OCT-based IOL power calculation formula demonstrates predictive accuracy equivalent to current standards for eyes with prior LVC.
- OCT technology offers a reliable solution for optimizing IOL power calculations in complex post-refractive surgery eyes.
Related Concept Videos
Focusing of Light in the Eye
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
